A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome
Clinical trial NCT00349284 · COMPLETED
Trial details
- NCT number
- NCT00349284
- Sponsor
- Solvay Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.